These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1407003)

  • 1. Molecular structural basis of ligand selectivity for 5-HT2 versus 5-HT1C cortical receptors.
    Pierce PA; Kim JY; Peroutka SJ
    Naunyn Schmiedebergs Arch Pharmacol; 1992 Jul; 346(1):4-11. PubMed ID: 1407003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High and low affinity 5-HT2 and 5-HT1C binding sites: responses to neonatal 5,7-DHT lesions in rat brain.
    Pranzatelli MR; Gregory CM
    Cytobios; 1993; 75(302-303):197-209. PubMed ID: 8243108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketanserin analogues: structure-affinity relationships for 5-HT2 and 5-HT1C serotonin receptor binding.
    Herndon JL; Ismaiel A; Ingher SP; Teitler M; Glennon RA
    J Med Chem; 1992 Dec; 35(26):4903-10. PubMed ID: 1479590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoradiographic characterization of (+-)-1-(2,5-dimethoxy-4-[125I] iodophenyl)-2-aminopropane ([125I]DOI) binding to 5-HT2 and 5-HT1c receptors in rat brain.
    Appel NM; Mitchell WM; Garlick RK; Glennon RA; Teitler M; De Souza EB
    J Pharmacol Exp Ther; 1990 Nov; 255(2):843-57. PubMed ID: 2243353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of phenylalkylamine derivatives at 5-HT1C and 5-HT2 serotonin receptors: evidence for a lack of selectivity.
    Glennon RA; Raghupathi R; Bartyzel P; Teitler M; Leonhardt S
    J Med Chem; 1992 Feb; 35(4):734-40. PubMed ID: 1542100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin receptors in the human brain. II. Characterization and autoradiographic localization of 5-HT1C and 5-HT2 recognition sites.
    Hoyer D; Pazos A; Probst A; Palacios JM
    Brain Res; 1986 Jun; 376(1):97-107. PubMed ID: 2941113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of typical and atypical antipsychotics to 5-HT1C and 5-HT2 sites: clozapine potently interacts with 5-HT1C sites.
    Canton H; Verrièle L; Colpaert FC
    Eur J Pharmacol; 1990 Nov; 191(1):93-6. PubMed ID: 1982659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonism of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane stimulus with a newly identified 5-HT2- versus 5-HT1C-selective antagonist.
    Ismaiel AM; De Los Angeles J; Teitler M; Ingher S; Glennon RA
    J Med Chem; 1993 Aug; 36(17):2519-25. PubMed ID: 8355253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competitive antagonism by recognized 5-HT2 receptor antagonists at 5-HT1C receptors in pig choroid plexus.
    Sahin-Erdemli I; Schoeffter P; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Aug; 344(2):137-42. PubMed ID: 1944609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of receptor domains that modify ligand binding to 5-hydroxytryptamine2 and 5-hydroxytryptamine1c serotonin receptors.
    Choudhary MS; Craigo S; Roth BL
    Mol Pharmacol; 1992 Oct; 42(4):627-33. PubMed ID: 1435740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential binding of ergot compounds to human versus rat 5-HT2 cortical receptors.
    Hagen JD; Pierce PA; Peroutka SJ
    Biol Signals; 1994; 3(5):223-9. PubMed ID: 7704103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
    Titeler M; Lyon RA; Davis KH; Glennon RA
    Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental regulation of 5-HT2 and 5-HT1c mRNA and receptor levels.
    Roth BL; Hamblin MW; Ciaranello RD
    Brain Res Dev Brain Res; 1991 Jan; 58(1):51-8. PubMed ID: 2015654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excitatory responses to serotonin (5-HT) in neurons of the rat piriform cortex: evidence for mediation by 5-HT1C receptors in pyramidal cells and 5-HT2 receptors in interneurons.
    Sheldon PW; Aghajanian GK
    Synapse; 1991 Nov; 9(3):208-18. PubMed ID: 1776132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gaps and peculiarities in 5-HT2 receptor studies.
    Leysen JE
    Neuropsychopharmacology; 1990; 3(5-6):361-9. PubMed ID: 2078272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of spinal 5-HT1C binding sites in the rat: characterization of [3H]mesulergine binding.
    Pranzatelli MR; Murthy JN; Pluchino RS
    J Pharmacol Exp Ther; 1992 Apr; 261(1):161-5. PubMed ID: 1560361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a 5-HT1 recognition site in human brain membranes different from 5-HT1A, 5-HT1B and 5-HT1C sites.
    Hoyer D; Waeber C; Pazos A; Probst A; Palacios JM
    Neurosci Lett; 1988 Mar; 85(3):357-62. PubMed ID: 2966310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
    Hoyer D; Engel G; Kalkman HO
    Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of 5-HT2 and 5-HT1C serotonin receptor levels. Methodology and mechanisms.
    Roth BL; Hamblin M; Ciaranello RD
    Neuropsychopharmacology; 1990; 3(5-6):427-33. PubMed ID: 2078277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of serotonin receptors recognized by anti-idiotypic antibodies.
    Tamir H; Liu KP; Hsiung SC; Yu PY; Kirchgessner AL; Gershon MD
    J Neurochem; 1991 Sep; 57(3):930-42. PubMed ID: 1861158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.